Karyn Aalami Goodman was named associate director for clinical research at Mount Sinai’s The Tisch Cancer Institute. She is also professor and vice chair for research and quality in the Department of Radiation Oncology.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
